Kathryn Ball

Supplementary Figures S1-10 from Design and Preclinical Evaluation of a Novel B7-H4–Directed Antibody–Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305

Krista Kinneer, Philipp Wortmann, Zachary A. Cooper, Niall J. Dickinson et autres

Supplementary Materials and Methods from Design and Preclinical Evaluation of a Novel B7-H4–Directed Antibody–Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305

Krista Kinneer, Philipp Wortmann, Zachary A. Cooper, Niall J. Dickinson et autres

Supplementary Figures S11-18 from Design and Preclinical Evaluation of a Novel B7-H4–Directed Antibody–Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305

Krista Kinneer, Philipp Wortmann, Zachary A. Cooper, Niall J. Dickinson et autres

Supplementary Tables S1-4 from Design and Preclinical Evaluation of a Novel B7-H4–Directed Antibody–Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305

Krista Kinneer, Philipp Wortmann, Zachary A. Cooper, Niall J. Dickinson et autres

An affinity-modulated T cell engager targeting Claudin 18.2 shows potent anti-tumor activity with limited cytokine release

Miguel B. Gaspar, Marina Natoli, Laure Castan, Sharif Rahmy et autres

gb, us, cn, kr, ch, es, br (code pays fourni par la source)

Quantitative systems pharmacology modeling of pyrrolobenzodiazepine antibody-drug conjugates targeting BCMA

Inez Lam, David Dai, Rosalinda H. Arends, Venkatesh Pilla Reddy et autres

us, au, pl, kr (code pays fourni par la source)

Extensive Biotransformation Profiling of AZD8205, an Anti-B7-H4 Antibody-Drug Conjugate, Elucidates Pathways Underlying Its Stability In Vivo

Yue Huang, Hui Yin Tan, Jiaqi Yuan, Ruipeng Mu et autres

us, gb (code pays fourni par la source)

Extensive Biotransformation Profiling of AZD8205, an Anti-B7-H4 Antibody-Drug Conjugate, Elucidates Pathways Underlying its Stability In Vivo

Yue Huang, Hui Yin Tan, Jiaqi Yuan, Ruipeng Mu et autres

us, gb (code pays fourni par la source)

Extensive Biotransformation Profiling of AZD8205, an Anti-B7-H4 Antibody-Drug Conjugate, Elucidates Pathways Underlying its Stability In Vivo

Yue Huang, Hui Yin Tan, Jiaqi Yuan, Ruipeng Mu et autres

us, gb (code pays fourni par la source)

1169 AZD5863: a specific, potent, affinity-optimized claudin 18.2 and CD3 binding T cell-engager that elicits low cytokine release and is capable of bystander killing

Miguel B. Gaspar, Marina Natoli, Laure Castan, Sharif Rahmy et autres

gb, sg, pl, kr, us (code pays fourni par la source)

Multiplex Bioanalytical Methods for Comprehensive Characterization and Quantification of the Unique Complementarity-Determining-Region Deamidation of MEDI7247, an Anti-ASCT2 Pyrrolobenzodiazepine Antibody–Drug Conjugate

Yue Huang, Jiaqi Yuan, Ruipeng Mu, Kathryn Ball et autres

us, gb (code pays fourni par la source)

Supplementary Data from Efficacy, Tolerability, and Pharmacokinetic Studies of Antibody–Drug Conjugates Containing a Low-Potency Pyrrolobenzodiazepine Dimer

Stephen J. Gregson, Kathryn Pugh, Neki Patel, Shameen Afif-Rider et autres